Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Aug 21, 2025; 31(31): 109857
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.109857
Figure 3
Figure 3 Prognosis in groups divided according to the cutoff value of combination of tumor deposits and negative lymph node. A: Combination of tumor deposits and negative lymph node (NLNTD) predicting disease-free survival (P = 0.005); B: NLNTD predicting overall survival (P = 0.052); C: NLNTD predicting cancer-specific survival (P = 0.019). NLNTD: Combination of tumor deposits and negative lymph node.